R
57
-3
MOS
50
2
PBI
40
-2
COP
48
-2
TXN
48
8
CMCSA
52
6
GLW
50
2
CI
72
2
AN
38
-2
UPS
40
2
XYL
31
-4
WDC
40
2
LB
60
-4
IR
47
-2
K
57
-2
KMX
53
-2
MCHP
43
-3
HRB
51
2
NDAQ
63
4
KO
65
-3
R
57
-3
MOS
50
2
PBI
40
-2
COP
48
-2
TXN
48
8
CMCSA
52
6
GLW
50
2
CI
72
2
AN
38
-2
UPS
40
2
XYL
31
-4
WDC
40
2
LB
60
-4
IR
47
-2
K
57
-2
KMX
53
-2
MCHP
43
-3
HRB
51
2
NDAQ
63
4
KO
65
-3
Financhill
Back

ResMed 10K Form

Buy
52

RMD
ResMed

Last Price:
$221.32
Seasonality Move:
5.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-10-27 10Q RMD/ResMed Quarterly
2023-04-28 10Q RMD/ResMed Quarterly
2023-01-27 10Q RMD/ResMed Quarterly
2022-10-28 10Q RMD/ResMed Quarterly
2022-04-29 10Q RMD/ResMed Quarterly
2022-01-28 10Q RMD/ResMed Quarterly

Receive RMD News And Ratings

See the #1 stock for the next 7 days that we like better than RMD

RMD Financial Statistics

Sales & Book Value

Annual Sales: $4.7B
Cash Flow: $285.2M
Price / Cash Flow: 23.48
Annual Sales: $35.77
Price / Book: 6.16

Profitability

EPS (TTM): 8.47000
Net Income (TTM): $1.2B
Gross Margin: $2.7B
Return on Equity: 25.56%
Return on Assets: 17.86%

ResMed Earnings Forecast

Key ResMed Financial Ratios

  • The Gross Profit Margin over the past 32 years for RMD is 56.67%.
  • The Selling, General & Administrative Expenses for RMD have been equal to 19.57% of Gross Profit Margin.
  • The Research & Development expenses have been 6.56% of Revenue.
  • The Interest Expense is 4.48% of Operating Income.
  • The Net Earning history of RMD is 21.79% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 25 years.

ResMed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: RMD
CUSIP: 761152
Website: resmed.com

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 3.33
Quick Ratio: 1.74

Price-to-Earnings

Trailing P/E Ratio: 31.83
Forward P/E Ratio: 21.16

RMD Technical Analysis vs Fundamental Analysis

Buy
52
ResMed (RMD) is a Buy

Is ResMed a Buy or a Sell?

  • ResMed stock is rated a Buy
    The current ResMed [RMD] share price is $220.25. The Score for RMD is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.